SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 101.48   0.09 (+0.09%) Volume: 13.39k 10:15 AM EST 20-Feb-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
DEFA14AAdditional proxy soliciting materials - definitive304/24/2019
8-KCurrent report pursuant to Section 13 or 15(d)404/22/2019
SC 13GStatement of acquisition of beneficial ownership by individuals504/15/2019
4Statement of changes in beneficial ownership of securities103/15/2019
4Statement of changes in beneficial ownership of securities103/15/2019
4Statement of changes in beneficial ownership of securities103/15/2019
8-KCurrent report pursuant to Section 13 or 15(d)20503/12/2019
8-KCurrent report pursuant to Section 13 or 15(d)803/06/2019
8-KCurrent report pursuant to Section 13 or 15(d)5203/05/2019
10-KAnnual report pursuant to Section 13 or 15(d)14302/28/2019
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/13/2019
123456789101112131415